Tā te kiritaki whai wāhi
Consumer opportunities
Read more about the current open opportunities for consumers to get involved.
Tā te kiritaki whai wāhi
Read more about the current open opportunities for consumers to get involved.
At Te Tāhū Hauora, we support consumers being actively involved in decision-making about their health, at all levels.
Health services, including hospitals, government agencies and other services, require consumer representatives to co-design the planning, design, delivery and evaluation of health services.
Below are the current open opportunities for consumers to get involved.
Please note Te Tāhū Hauora publishes these opportunities on behalf of a range of different agencies and groups in the health sector. Please contact each provider directly using the information provided in the listing.
Do you have an opportunity you think consumer health forum Aotearoa members should know about?
If so, please submit an expression of interest for consumer and whānau representatives here.
Breast Cancer Foundation NZ is seeking up to seven consumers to join an advisory group that will advise on the development of a new improvement programme for people taking endocrine therapy (hormone-blocking therapy) after treatment for breast cancer.
As a consumer representative, you will guide and advise the programme on issues related to improving survival rates for patients with breast cancer.
We are looking for consumers who have had recent experience with:
or
We are also seeking people who have knowledge about the needs of Māori and/or Pacific peoples experiencing long-term breast cancer treatment.
As a consumer representative on this advisory group, you will provide advice from a consumer’s perspective on aspects such as:
These are the meetings we propose:
Consumers will be paid for their time at the following rates:
These rates are guided by the consumer advisory group remuneration policy of Te Aho o Te Kahu, the Cancer Control Agency.
Please choose one of these options:
The aim of the project is to address the barriers that patients with hormone-receptor-positive breast cancer face when prescribed a long-term endocrine-blocking medication. This project emerged from a comprehensive telehealth service run by nursing staff at Breast Cancer Foundation NZ. The project is currently informed by clinicians and nurses with extensive experience of endocrine therapy across the country, a patient survey provider and a software company specialising in health data.
If you have any questions or would like more information about this opportunity, please email: hannah.holtkamp@bcf.org.nz.
Applications close 17 July 2024.
Health New Zealand – Te Whatu Ora is seeking two consumer representatives who have participated in bowel screening and/or had a colonoscopy as part of the bowel screening process, to join a working group aimed at delivering a new test to patients who need a colonoscopy.
The faecal immunochemical test (FIT) symptomatic project will decide how to introduce FIT to prioritise patients for colonoscopy, for those already on a non-urgent symptomatic waiting list and for new referrals.
There is a preference, but not limited to, Māori and Pacific peoples and people with accessibility needs.
The project involves representation of leaders from other consumer groups, some clinicians, as well as project support.
As a consumer representative on the FIT equity working group you are:
If you have any questions or would like more information about the role, email Marni Adlam at marni.adlam@tewhatuora.govt.nz.
Applications close on 1 August 2024.
Breast Cancer Foundation NZ is seeking up to seven consumers to join an advisory group that will advise on the development of a new improvement programme for people taking endocrine therapy (hormone-blocking therapy) after treatment for breast cancer.
As a consumer representative, you will guide and advise the programme on issues related to improving survival rates for patients with breast cancer.
We are looking for consumers who have had recent experience with:
or
We are also seeking people who have knowledge about the needs of Māori and/or Pacific peoples experiencing long-term breast cancer treatment.
As a consumer representative on this advisory group, you will provide advice from a consumer’s perspective on aspects such as:
These are the meetings we propose:
Consumers will be paid for their time at the following rates:
These rates are guided by the consumer advisory group remuneration policy of Te Aho o Te Kahu, the Cancer Control Agency.
Please choose one of these options:
The aim of the project is to address the barriers that patients with hormone-receptor-positive breast cancer face when prescribed a long-term endocrine-blocking medication. This project emerged from a comprehensive telehealth service run by nursing staff at Breast Cancer Foundation NZ. The project is currently informed by clinicians and nurses with extensive experience of endocrine therapy across the country, a patient survey provider and a software company specialising in health data.
If you have any questions or would like more information about this opportunity, please email: hannah.holtkamp@bcf.org.nz.
Applications close 17 July 2024.
Health New Zealand – Te Whatu Ora is seeking two consumer representatives who have participated in bowel screening and/or had a colonoscopy as part of the bowel screening process, to join a working group aimed at delivering a new test to patients who need a colonoscopy.
The faecal immunochemical test (FIT) symptomatic project will decide how to introduce FIT to prioritise patients for colonoscopy, for those already on a non-urgent symptomatic waiting list and for new referrals.
There is a preference, but not limited to, Māori and Pacific peoples and people with accessibility needs.
The project involves representation of leaders from other consumer groups, some clinicians, as well as project support.
As a consumer representative on the FIT equity working group you are:
If you have any questions or would like more information about the role, email Marni Adlam at marni.adlam@tewhatuora.govt.nz.
Applications close on 1 August 2024.